INTERNATIONAL PATENT: GARUDA THERAPEUTICS, INC., SHAH, DHVANIT, SINGH, GURINDER FILES APPLICATION FOR "IMMUNE COMPATIBLE CELLS FOR ALLOGENEIC CELL THERAPIES TO COVER GLOBAL, ETHNIC, OR DISEASE- SPECIFIC POPULATIONS"

GENEVA, Oct. 20 -- GARUDA THERAPEUTICS, INC. (215 First St. Suites 340-350Cambridge, Massachusetts 02142), SHAH, Dhvanit (c/o Garuda Therapeutics, Inc.215 First St. Suites 340-350Cambridge, Massachusetts 02142), SINGH, Gurinder (c/o Garuda Therapeutics, Inc.215 First St. Suites 340-350Cambridge, Massachusetts 02142) filed a patent application (PCT/US2025/024169) for "IMMUNE COMPATIBLE CELLS FOR ALLOGENEIC CELL THERAPIES TO COVER GLOBAL, ETHNIC, OR DISEASE- SPECIFIC POPULATIONS" on Apr 10, 2025. With publication no. WO/2025/217462, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World...